2025 CPT® Code Updates ( CDM Focused )

© 2024 Health Catalyst Inc. All Rights Reserved.
2025 CPT®
Code Updates (CDM Focused)
Jennifer Bishop | RHIT, CCS, CCS-P, CHRI

Disclaimer Statement
This presentation was current at the time it was published or provided via the
web and is designed to provide accurate and authoritative information
regarding the subject matter covered. The information provided is only
intended to be a general overview with the understanding that neither the
presenter nor the event sponsor is engaged in rendering specific coding advice.
It is not intended to take the place of either the written policies or regulations.
We encourage participants to review the specific regulations and other
interpretive materials, as necessary.
All CPT codes are trademarked by the America Medical Association (AMA) and
all revenue codes are copyrighted by the American Hospital Association (AHA).

Overview of 2025 Changes
CPT® Section Additions Deletions Revisions
Evaluation &
Management
17 3 0
Anesthesia 0 0 0
Surgery 33 13 6
Radiology 6 0 0
Pathology & Laboratory 13 6 5
PLA & MAAA 10 3 2
Medicine 5 3 21
Category II 0 0 0
Category III 47 13 1
Totals 131 43 34
• Totals do not include codes added, deleted, or revised in CY 2024 but appearing for the first time in the CY 2025 book
• Revised totals do not include codes with changes to short or medium descriptions only

Changes to
Radiology Section

Added Codes - Radiology Section
 Six New Codes Added to Report MR Safety Procedures
 76014 - MR safety implant and/or foreign body assessment by trained clinical staff, including
identification and verification of implant components from appropriate sources (eg, surgical reports,
imaging reports, medical device databases, device vendors, review of prior imaging), analyzing current
MR conditional status of individual components and systems, and consulting published professional
guidance with written report; initial 15 minutes
 76015 - MR safety implant and/or foreign body assessment by trained clinical staff, including
identification and verification of implant components from appropriate sources (eg, surgical reports,
imaging reports, medical device databases, device vendors, review of prior imaging), analyzing current
MR conditional status of individual components and systems, and consulting published professional
guidance with written report; each additional 30 minutes (List separately in addition to code for primary
procedure)
 76016 - MR safety determination by a physician or other qualified health care professional responsible
for the safety of the MR procedure, including review of implant MR conditions for indicated MR
examination, analysis of risk vs clinical benefit of performing MR examination, and determination of MR
equipment, accessory equipment, and expertise required to perform examination, with written report

New Section and Guidelines for MR Safety
Procedures
 76014-76016 are designed to be performed in advance of the procedure date, unless
procedure is performed emergently
 76014 and 76015 report the clinical staff work only to identify and verify the safety of
implanted devices
 76014 and 76015 are time-based codes that must exceed the mid-point to report
 76016 is a risk-benefit analysis performed by a physician or QHP done for devices that may
cause issues; do NOT use for MR-safe devices or devices that won’t limit the MR procedure
 All codes require written reports

Added Codes - Radiology Section
 Six New Codes Added to Report MR Safety Procedures
 76017 - MR safety medical physics examination customization, planning and performance monitoring by
medical physicist or MR safety expert, with review and analysis by physician or other qualified health
care professional to prioritize and select views and imaging sequences, to tailor MR acquisition specific
to restrictive requirements or artifacts associated with MR conditional implants or to mitigate risk of
non-conditional implants or foreign bodies, with written report
 76018 - MR safety implant electronics preparation under supervision of physician or other qualified
health care professional, including MR-specific programming of pulse generator and/or transmitter to
verify device integrity, protection of device internal circuitry from MR electromagnetic fields, and
protection of patient from risks of unintended stimulation or heating while in the MR room, with written
report
 76019 - MR safety implant positioning and/or immobilization under supervision of physician or other
qualified health care professional, including application of physical protections to secure implanted
medical device from MR-induced translational or vibrational forces, magnetically induced functional
changes, and/or prevention of radiofrequency burns from inadvertent tissue contact while in the MR
room, with written report

New Section and Guidelines for MR Safety
Procedures
 76017-76019 are performed on the day of the procedure and require the involvement of a
physician or QHP directing the technologist
 76017 reports a patient safety exam and monitoring done to mitigate risk to the patient done
real-time during the exam
 76018 reports programming of medical devices in the MR suite before and after procedure
 76019 reports interacting with the patient to position or immobilize to keep the device from
shifting
 All three codes can be reported for the same MR procedure
 All require a written report to document specifics
 Most codes can be reported, even if MR is not completed (except for 76017)

Added Guidelines for Angiography
 Diagnostic angiography performed at a separate session from an interventional
procedure is separately reported
 Add-on code 75774 may be used with both arteries and veins for each additional
vessel studied
 Arteriography and venography

Changes to
Laboratory &
Pathology Section

Added Code – Tier I Molecular Pathology
 81195 – Cytogenomic (genome-wide) analysis, hematologic malignancy, structural
variants and copy number variants, optical genome mapping (OGM)
– Comprehensive assessment, looking for structural and copy number variants using molecular-
based technologies rather than sequencing
– Cytogenomics: “A comprehensive genome-wide analysis of chromosomal and genetic
abnormalities using molecular-based technologies.”

Added Codes – Multianalyte Assays
 81515 - Infectious disease, bacterial vaginosis and vaginitis, real-time PCR amplification of DNA
markers for Atopobium vaginae, Atopobium species, Megasphaera type 1, and Bacterial Vaginosis
Associated Bacteria-2 (BVAB-2), utilizing vaginal-fluid specimens, algorithm reported as positive or
negative for high likelihood of bacterial vaginosis, includes separate detection of Trichomonas vaginalis
and Candida species (C. albicans, C. tropicalis, C. parapsilosis, C. dubliniensis), Candida
glabrata/Candida krusei, when reported
– Cepheid® BV Test
– Previously reported using 0352U, which has been deleted
 81558 - Transplantation medicine (allograft rejection, kidney), mRNA, gene expression profiling by
quantitative polymerase chain reaction (qPCR) of 139 genes, utilizing whole blood, algorithm reported
as a binary categorization as transplant excellence, which indicates immune quiescence, or not
transplant excellence, indicating subclinical rejection
– TruGraf Kidney

Deleted Codes – Multianalyte Assays
Deleted Code Suggested Replacement Codes
81433 – Hereditary breast cancer-related disorders (eg, hereditary breast
cancer, hereditary ovarian cancer, hereditary endometrial cancer);
duplication/deletion analysis panel, must include analyses for BRCA1, BRCA2,
MLH1, MSH2, and STK11
81479
81436 - Hereditary colon cancer disorders (eg, Lynch syndrome, PTEN
hamartoma syndrome, Cowden syndrome, familial adenomatosis polyposis);
duplication/deletion analysis panel, must include analysis of at least 5 genes,
including MLH1, MSH2, EPCAM, SMAD4, and STK11
81479
81438 - Hereditary neuroendocrine tumor disorders (eg, medullary thyroid
carcinoma, parathyroid carcinoma, malignant pheochromocytoma or
paraganglioma); duplication/deletion analysis panel, must include analyses for
SDHB, SDHC, SDHD, and VHL
81479

Revised Codes – Multianalyte Assays
Code 2025 Long Description 2024 Long Description
81432 Hereditary breast cancer-related disorders (eg, hereditary breast cancer,
hereditary ovarian cancer, hereditary endometrial cancer, hereditary
pancreatic cancer, hereditary prostate cancer), genomic sequence analysis
panel, 5 or more genes, interrogation for sequence variants and copy
number variants
Hereditary breast cancer-related disorders (eg, hereditary breast cancer,
hereditary ovarian cancer, hereditary endometrial cancer); genomic
sequence analysis panel, must include sequencing of at least 10 genes,
always including BRCA1, BRCA2, CDH1, MLH1, MSH2, MSH6, PALB2,
PTEN, STK11, and TP53
81435
Hereditary colon cancer-related disorders (eg, Lynch syndrome, PTEN
hamartoma syndrome, Cowden syndrome, familial adenomatosis polyposis),
genomic sequence analysis panel, 5 or more genes, interrogation for
sequence variants and copy number variants
Hereditary colon cancer disorders (eg, Lynch syndrome, PTEN
hamartoma syndrome, Cowden syndrome, familial adenomatosis
polyposis); genomic sequence analysis panel, must include sequencing
of at least 10 genes, including APC, BMPR1A, CDH1, MLH1, MSH2,
MSH6, MUTYH, PTEN, SMAD4, and STK11
81437
Hereditary neuroendocrine tumor-related disorders (eg, medullary thyroid
paraganglioma), genomic sequence analysis panel, 5 or more genes,
interrogation for sequence variants and copy number variants
Hereditary neuroendocrine tumor disorders (eg, medullary thyroid
paraganglioma); genomic sequence analysis panel, must include
sequencing of at least 6 genes, including MAX, SDHB, SDHC, SDHD,
TMEM127, and VHL

Added Codes – Chemistry
 82233 – Beta-amyloid; 1-40 (Abeta 40)
 82234 - Beta-amyloid; 1-42 (Abeta 42)
 82233/82234 frequently done as a ratio; both codes would be reported
 Diagnosis of Alzheimer’s disease in patients who present with mild cognitive impairment
 Not to be used for screening of patients
 There are also PLA codes for these tests, which should be used when a specific proprietary
assay is performed
 83884 - Neurofilament light chain (NfL)
 84393 - Tau, phosphorylated (eg, pTau 181, pTau 217), each
 84394 - Tau, total (tTau)

Added Code – Immunology
 86581 - Streptococcus pneumoniae antibody (IgG), serotypes, multiplex
immunoassay, quantitative
– Looks for impaired antibody response in patients who don’t respond to treatment and
get frequent Strep infections

Deleted Codes – Immunology
86327 - Immunoelectrophoresis; crossed (2-dimensional assay) 86849
86490 - Skin test; coccidioidomycosis Use 86635 if performing
coccidioidomycosis antibody testing

Added Codes – Microbiology
 87513 - Infectious agent detection by nucleic acid (DNA or RNA); Helicobacter pylori
(H. pylori), clarithromycin resistance, amplified probe technique
– Assay that both identifies H. pylori and clarithromycin resistance
– For H. pylori without clarithromycin resistance, see 87798
– For H. pylori stool testing, see 87338
– For H. pylori immunoassay, see 87339
 87564 - Infectious agent detection by nucleic acid (DNA or RNA); Mycobacterium
tuberculosis, rifampin resistance, amplified probe technique
– For identification without rifampin resistance testing, see 87555-87557

Added Codes – Microbiology
 87594 - Infectious agent detection by nucleic acid (DNA or RNA); Pneumocystis
jirovecii, amplified probe technique
– Previously called Pneumocystis carinii; seen in immunodeficient patients
 87626 - Infectious agent detection by nucleic acid (DNA or RNA); Human
Papillomavirus (HPV), separately reported high-risk types (eg, 16, 18, 31, 45, 51, 52)
and high-risk pooled result(s)
– Replaced Category III code 0500T
– Use when at least 5 high-risk subtypes are reported
– Do NOT report with 87624 (singular pooled result of high-risk HPV types)
– Do NOT report with 87625 (HPV types 16 and 18 only, with 45, if performed)

Revised Code – Microbiology
87624 Infectious agent detection by nucleic acid (DNA or RNA);
Human Papillomavirus (HPV), high-risk types (eg, 16, 18,
31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68), pooled result
Infectious agent detection by nucleic acid (DNA or
RNA); Human Papillomavirus (HPV), high-risk types
(eg, 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68)

Deleted Code – Surgical Pathology
Deleted Code Suggested Replacement Code
88388 - Macroscopic examination, dissection, and preparation of tissue for non-
microscopic analytical studies (eg, nucleic acid-based molecular studies); in
conjunction with a touch imprint, intraoperative consultation, or frozen section,
each tissue preparation (eg, a single lymph node) (List separately in addition to
code for primary procedure)

Revised Code – Surgical Pathology
88387 Macroscopic examination, dissection, and preparation
of tissue for non-microscopic analytical studies (eg,
nucleic acid-based molecular studies), each tissue
preparation (eg, a single lymph node)
Macroscopic examination, dissection, and preparation
of tissue for non-microscopic analytical studies (eg,
nucleic acid-based molecular studies); each tissue
preparation (eg, a single lymph node)

New Guidelines for Surgical Pathology
 Services 88300 through 88309 include accession, examination, and reporting but
do not include services reported using 88311-88387 which may be additionally
coded when provided
 Surgical pathology procedures not specified in codes 88300-88387 may be
reported using unlisted code 88399

Changes to
Proprietary
Laboratory Analyses
(PLA) Codes

Added Codes – PLA
 0521U - Rheumatoid factor IgA and IgM, cyclic citrullinated peptide (CCP) antibodies,
and scavenger receptor A (SR-A) by immunoassay, blood
– Seronegative Rheumatoid Arthritis Panel from KSL Diagnostics-Beutner Laboratories, Inc
 0522U - Carbonic anhydrase VI, parotid specific/secretory protein and salivary protein
1 (SP1), IgG, IgM, and IgA antibodies, chemiluminescence, semiqualitative, blood
– Tissue Specific Markers for Early Diagnosis of Sjogren’s Disease from KSL Diagnostics, Inc

Added Codes – PLA
 0523U - Oncology (solid tumor), DNA, qualitative, next-generation sequencing (NGS)
of single-nucleotide variants (SNV) and insertion/deletions in 22 genes utilizing
formalin-fixed paraffin-embedded tissue, reported as presence or absence of
mutation(s), location of mutation(s), nucleotide change, and amino acid change
– oncoReveal™ CDx from Pillar Biosciences, Inc
 0524U - Obstetrics (preeclampsia), sFlt-1/PlGF ratio, immunoassay, utilizing serum or
plasma, reported as a value
– sFlt-1/PIGF from Thermo Fisher Scientific
– Testing for pregnant patients with hypertension to determine risk of progression to pre-eclampsia

Added Codes – PLA
 0525U - Oncology, spheroid cell culture, 11-drug panel (carboplatin, docetaxel,
doxorubicin, etoposide, gemcitabine, niraparib, olaparib, paclitaxel, rucaparib,
topotecan, veliparib) ovarian, fallopian, or peritoneal response prediction for each
drug
– 3D Predict™ Ovarian from Kiyatec®, Inc
– Guides drug treatment for patients with ovarian cancer
 0526U - Nephrology (renal transplant), quantification of CXCL10 chemokines, flow
cytometry, urine, reported as pg/mL creatinine baseline and monitoring over time
– CXCL10 Urine Test from One Lambda™, Inc

Added Codes – PLA
 0527U - Herpes simplex virus (HSV) types 1 and 2 and Varicella zoster virus (VZV),
amplified probe technique, each pathogen reported as detected or not detected
– Abbott Alinity™ m HSV 1 & 2/VZV Assay from Abbott Molecular
 0528U - Lower respiratory tract infectious agent detection, 18 bacteria, 8 viruses, and
7 antimicrobial-resistance genes, amplified probe technique, including reverse
transcription for RNA targets, each analyte reported as detected or not detected with
semiquantitative results for 15 bacteria
– BIOFIRE® FILMARRAY® Pneumonia (PN) Panel from bioMérieux
– Pinpoints the pathogen causing lower respiratory tract infection

Added Codes – PLA
 0529U - Hematology (venous thromboembolism [VTE]), genome-wide single-
nucleotide polymorphism variants, including F2 and F5 gene analysis, and Leiden
variant, by microarray analysis, saliva, report as risk score for VTE
– Lifetime Genomics Risk Assessment VTE from GenomicMD, Inc
 0530U - Oncology (pan-solid tumor), ctDNA, utilizing plasma, next-generation
sequencing (NGS) of 77 genes, 8 fusions, microsatellite instability, and tumor
mutation burden, interpretative report for single-nucleotide variants, copy-number
alterations, with therapy association
– LiquidHALLMARK® from Lucence Health, Inc
– Targets genes commonly associated with 15 cancers

Deleted Codes – PLA
0346U - Beta amyloid, Aβ40 and Aβ42 by liquid chromatography with tandem
mass spectrometry (LC-MS/MS), ratio, plasma
0352U - Infectious disease (bacterial vaginosis and vaginitis), multiplex
amplified probe technique, for detection of bacterial vaginosis-associated
bacteria (BVAB-2, Atopobium vaginae, and Megasphera type 1), algorithm
reported as detected or not detected and separate detection of Candida
species (C. albicans, C. tropicalis, C. parapsilosis, C. dubliniensis), Candida
glabrata/Candida krusei, and trichomonas vaginalis, vaginal-fluid specimen,
each result reported as detected or not detected

0380U - Drug metabolism (adverse drug reactions and drug response), targeted
sequence analysis, 20 gene variants and CYP2D6 deletion or duplication analysis
with reported genotype and phenotype
0428U - Oncology (breast), targeted hybrid-capture genomic sequence analysis
panel, circulating tumor DNA (ctDNA) analysis of 56 or more genes,
interrogation for sequence variants, gene copy number amplifications, gene
rearrangements, microsatellite instability, and tumor mutation burden

0448U - Oncology (lung and colon cancer), DNA, qualitative, next-generation
sequencing detection of single-nucleotide variants and deletions in EGFR and
KRAS genes, formalin-fixed paraffin-embedded (FFPE) solid tumor samples,
reported as presence or absence of targeted mutation(s), with recommended
therapeutic options
0456U - Autoimmune (rheumatoid arthritis), next-generation sequencing (NGS),
gene expression testing of 19 genes, whole blood, with analysis of anti-cyclic
citrullinated peptides (CCP) levels, combined with sex, patient global
assessment, and body mass index (BMI), algorithm reported as a score that
predicts nonresponse to tumor necrosis factor inhibitor (TNFi) therapy

Revised Codes – PLA
0095U Eosinophilic esophagitis, 2 protein biomarkers (Eotaxin-3 [CCL26 {C-C
motif chemokine ligand 26}] and Major Basic Protein [PRG2
{proteoglycan 2, pro eosinophil major basic protein}]), enzyme-linked
immunosorbent assays (ELISA), specimen obtained by esophageal string
test device, algorithm reported as probability of active or inactive
eosinophilic esophagitis
Eosinophilic esophagitis (Eotaxin-3 [CCL26 {C-C motif chemokine
ligand 26}] and major basic protein [PRG2 {proteoglycan 2, pro
eosinophil major basic protein}]), enzyme-linked immunosorbent
assays (ELISA), specimen obtained by esophageal string test device,
algorithm reported as probability of active or inactive eosinophilic
esophagitis
0365U Oncology (bladder), 10 protein biomarkers (A1AT, ANG, APOE, CA9, IL8,
MMP9, MMP10, PAI1, SDC1, and VEGFA) by immunoassays, urine,
diagnostic algorithm, including patient’s age, race and gender, reported
as a probability of harboring urothelial cancer
Oncology (bladder), analysis of 10 protein biomarkers (A1AT, ANG,
APOE, CA9, IL8, MMP9, MMP10, PAI1, SDC1, and VEGFA) by
immunoassays, urine, algorithm reported as a probability of
bladder cancer

Changes to Medicine
Section

Deleted Codes – Vaccines, Toxoids
90630 – Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative
free, for intradermal use
See influenza vaccine codes 90653-
90756
90654 - Influenza virus vaccine, trivalent (IIV3), split virus, preservative-free, for
intradermal use
See influenza vaccine codes 90653-
90756
• These vaccine products are no longer in use

Added Code – Ophthalmology
 92137 - Computerized ophthalmic
diagnostic imaging (eg, optical
coherence tomography [OCT]),
posterior segment, with
interpretation and report, unilateral
or bilateral; retina, including OCT
angiography
 New technique available to image retina
using OCT
 Provides additional information about
blood flow in the retina

Revised Codes – Ophthalmology
92132 Computerized ophthalmic diagnostic imaging (eg, optical
coherence tomography [OCT]), anterior segment, with
interpretation and report, unilateral or bilateral
Scanning computerized ophthalmic diagnostic imaging,
anterior segment, with interpretation and report, unilateral
or bilateral
coherence tomography [OCT]), posterior segment, with
interpretation and report, unilateral or bilateral; optic nerve
posterior segment, with interpretation and report, unilateral
or bilateral; optic nerve
coherence tomography [OCT]), posterior segment, with
interpretation and report, unilateral or bilateral; retina
posterior segment, with interpretation and report, unilateral
or bilateral; retina
• Scanning is not terminology that is currently used
• Addition of ‘optical coherence tomography [OCT]’ clarifies use of these codes

Revised Codes – Intracardiac EP Procedures/Studies
93656 Comprehensive electrophysiologic evaluation with
transseptal catheterizations, insertion and repositioning of
multiple electrode catheters, induction or attempted
induction of an arrhythmia including left or right atrial
pacing/recording, and intracardiac catheter ablation of atrial
fibrillation by pulmonary vein isolation, including intracardiac
electrophysiologic 3-dimensional mapping, intracardiac
echocardiography with imaging supervision and
interpretation, right ventricular pacing/recording, and His
bundle recording, when performed
Comprehensive electrophysiologic evaluation including
transseptal catheterizations, insertion and repositioning of
multiple electrode catheters with intracardiac catheter
ablation of atrial fibrillation by pulmonary vein isolation,
including intracardiac electrophysiologic 3-dimensional
mapping, intracardiac echocardiography including imaging
supervision and interpretation, induction or attempted
induction of an arrhythmia including left or right atrial
pacing/recording, right ventricular pacing/recording, and His
bundle recording, when performed
• Clarifies that transseptal catheterizations, insertion and repositioning of catheters, and induction are all part of the procedure
rather than optional components

Added Guidelines – Intracardiac EP
Procedures/Studies
 Single-site EP studies (93600-93603, 93610, 93612, 93618) may NOT be reported
separately when ablation (93653-93657) is performed at the same session
 93621 (LA pacing/recording) is a component of 93656 which may NOT be separately
reported
 93653 and 93654 include RV pacing/recording and His bundle recording when
indicated
 93622 (LV pacing/recording) may be reported in addition to 93653 and 93656
 93623 (programmed stimulation/pacing after IV drug infusion) may be reported in
addition to 93653, 93654, and 93656

Added Codes – Cerebrovascular Arterial Studies
 93896 - Vasoreactivity study performed with transcranial Doppler study of
intracranial arteries, complete (List separately in addition to code for primary
procedure)
 93897 - Emboli detection without intravenous microbubble injection performed with
transcranial Doppler study of intracranial arteries, complete (List separately in
addition to code for primary procedure)
 93898 - Venous-arterial shunt detection with intravenous microbubble injection
performed with transcranial Doppler study of intracranial arteries, complete (List
separately in addition to code for primary procedure)
• Three new add-on codes to avoid duplicate reporting of pre- and post-service work
since Doppler studies commonly are done with additional studies

Deleted Code – Cerebrovascular Arterial Studies
93890 – Transcranial Doppler study of the intracranial arteries; vasoreactivity
study
93896

Revised Codes – Cerebrovascular Arterial Studies
93893 Transcranial Doppler study of the intracranial arteries;
venous-arterial shunt detection with intravenous
microbubble injection
Transcranial Doppler study of the intracranial arteries;
emboli detection with intravenous microbubble injection
• Codes should be used when study is done independently from a transcranial Doppler study of the intracranial
arteries
• Do NOT report 93892 or 93893 in conjunction with 93886 or 93888

Added Guidelines – Cerebrovascular Arterial
Studies
 Used when a vasoreactivity study, emboli detection without IV microbubble injection
or venous-arterial shunt detection with IV microbubble injection is performed in
conjunction with a complete transcranial Doppler study on the same day
 Add-on codes are used in conjunction with complete transcranial Doppler study of
intracranial arteries (93886)
 Do NOT use when limited study is performed (93888)

Deleted Code – Neurology and Neuromuscular
Procedures
96003 – Dynamic fine wire electromyography, during walking or other
functional activities, 1 muscle
• No usage for fine wire EMG; 96002 remains to report surface EMG, which is still performed
• Explanatory notes added to this subsection to clarify that procedures described by 96000-96002 (motion analysis)
are performed in a dedicated space that can perform videotaping from all sides, computerized 3D kinematics, 3D
kinetics, and dynamic EMG

Added Code – Medical Genetics and Genetic
Counseling Services
 96041 - Medical genetics and genetic counseling services, each 30 minutes of total
time provided by the genetic counselor on the date of the encounter
• New code allows for reporting of total time rather than face-to-face time alone

Deleted Code – Medical Genetics and Genetic
Counseling Services
96040 – Medical genetics and genetic counseling services, each 30 minutes
face-to-face with patient/family
96041

Added Guidelines – Medical Genetics and
Genetic Counseling Services
 These services are provided by trained genetic counselors
– Structured family genetic history
– Construction of a pedigree
– Analysis of genetic risk
– Counseling of patient and family
 Not reported for services that require 15 minutes or less of genetic counselor’s time
 For group education of genetic risks by a non-physician, see 98961/98962
 When physician provides genetic counseling or risk-factor reduction to asymptomatic
patients, see 99401-99412
 When physician provides genetic counseling, see appropriate E/M codes

Revised Codes – Acupuncture
97811 Acupuncture, 1 or more needles; without electrical
stimulation, each additional 15 minutes of personal one-on-
one contact with the patient, with insertion of needle(s) (List
separately in addition to code for primary procedure)
Acupuncture, 1 or more needles; without electrical
stimulation, each additional 15 minutes of personal one-
on-one contact with the patient, with reinsertion of
needle(s) (List separately in addition to code for primary
procedure)
97814 Acupuncture, 1 or more needles; with electrical stimulation,
each additional 15 minutes of personal one-on-one contact
with the patient, with insertion of needle(s) (List separately
in addition to code for primary procedure)
Acupuncture, 1 or more needles; with electrical
stimulation, each additional 15 minutes of personal one-
on-one contact with the patient, with reinsertion of
needle(s) (List separately in addition to code for primary
procedure)

Revised Codes – Education & Training
98960 Education and training for patient self-management by a
nonphysician qualified health care professional using a
standardized curriculum, face-to-face with the patient (could
include caregiver/family) each 30 minutes; individual patient
Education and training for patient self-management by a
qualified, nonphysician health care professional using a
standardized curriculum, face-to-face with the patient
(could include caregiver/family) each 30 minutes;
individual patient
include caregiver/family) each 30 minutes; 2-4 patients
(could include caregiver/family) each 30 minutes; 2-4
patients
include caregiver/family) each 30 minutes; 5-8 patients
(could include caregiver/family) each 30 minutes; 5-8
patients

Revised Codes – Telephone Services
98966 Telephone assessment and management service provided by a nonphysician
qualified health care professional to an established patient, parent, or
guardian not originating from a related assessment and management service
provided within the previous 7 days nor leading to an assessment and
management service or procedure within the next 24 hours or soonest
available appointment; 5-10 minutes of medical discussion
Telephone assessment and management service provided by a qualified
nonphysician health care professional to an established patient, parent,
or guardian not originating from a related assessment and management
service provided within the previous 7 days nor leading to an assessment
and management service or procedure within the next 24 hours or
soonest available appointment; 5-10 minutes of medical discussion

Revised Codes – Online Digital Assessment &
Management Services
98970 Nonphysician qualified health care professional online digital
assessment and management, for an established patient, for up
to 7 days, cumulative time during the 7 days; 5-10 minutes
Qualified nonphysician health care professional online
digital assessment and management, for an established
patient, for up to 7 days, cumulative time during the 7 days;
5-10 minutes
5-10 minutes
5-10 minutes

Added Guidelines – Nonphysician QHP Services
 98960-98962 are used to report education & training for patient self-management by
a non-physician practitioner using a standardized curriculum that is consistent with
established guidelines and standards

Revised Codes – Remote Therapeutic Monitoring
Services
98975 Remote therapeutic monitoring (eg, therapy adherence, therapy
response, digital therapeutic intervention); initial set-up and patient
education on use of equipment
Remote therapeutic monitoring (eg, therapy adherence, therapy
response); initial set-up and patient education on use of equipment
response, digital therapeutic intervention); device(s) supply for data
access or data transmissions to support monitoring of respiratory
system, each 30 days
response); device(s) supply with scheduled (eg, daily) recording(s)
and/or programmed alert(s) transmission to monitor respiratory
access or data transmissions to support monitoring of musculoskeletal
and/or programmed alert(s) transmission to monitor
musculoskeletal system, each 30 days
access or data transmissions to support monitoring of cognitive
behavioral therapy, each 30 days
and/or programmed alert(s) transmission to monitor cognitive
behavioral therapy, each 30 days

Changes to Category III
Codes

Added Codes - New & Emerging Technology
Code Long Description
0902T QTc interval derived by augmentative algorithmic analysis of input from an external, patient-activated mobile
ECG device
0903T Electrocardiogram, algorithmically generated 12-lead ECG from a reduced-lead ECG; with interpretation and
report
0904T Electrocardiogram, algorithmically generated 12-lead ECG from a reduced-lead ECG; tracing only
0905T Electrocardiogram, algorithmically generated 12-lead ECG from a reduced-lead ECG; interpretation and report
only
 0902T describes analysis of ECG data from a mobile device to calculate QTc using algorithm
 0903T-0905T describe analysis of a reduced-lead ECG to produce a 12-lead ECG result using algorithm
 Do NOT report with 93000, 93005, 93010, 93040, 93041, 93042

Added Codes - New & Emerging Technology
0906T Concurrent optical and magnetic stimulation (COMS) therapy, wound assessment and dressing care; first
application, total wound(s) surface area less than or equal to 50 sq cm
0907T Concurrent optical and magnetic stimulation (COMS) therapy, wound assessment and dressing care; each
additional application, total wound(s) surface area less than or equal to 50 sq cm (List separately in addition to
code for primary procedure)
 Non-invasive approach to heal wounds that have demonstrated no significant healing after 30 days of
standard wound care

Added Codes
New & Emerging Technology
0911T Electronic analysis of implanted integrated neurostimulation system, vagus nerve; without programming by physician or
other qualified health care professional
0912T Electronic analysis of implanted integrated neurostimulation system, vagus nerve; with programming by physician or
other qualified health care professional
 Implantation, replacement, and removal of device are reported using new Category III codes 0908T-0910T

Added Codes
0926T Programming device evaluation (in person) with iterative adjustment of the implantable device to test the function of
the device and select optimal permanent programmed values with analysis, including review and report, implantable
cardiac contractility modulation-defibrillation system
0927T Interrogation device evaluation (in person) with analysis, review, and report, including connection, recording, and
disconnection, per patient encounter, implantable cardiac contractility modulation-defibrillation system
0928T Interrogation device evaluation (remote), up to 90 days, cardiac contractility modulation-defibrillation system with
interim analysis and report(s) by a physician or other qualified health care professional
0929T Interrogation device evaluation (remote), up to 90 days, cardiac contractility modulation-defibrillation system, remote
data acquisition(s), receipt of transmissions, technician review, technical support, and distribution of results
 Implantation, replacement, repositioning, and removal of device are reported using new Category III codes 0915T-0925T

Added Codes
0930T Electrophysiologic evaluation of cardiac contractility modulation-defibrillator leads, including defibrillation-threshold
evaluation (induction of arrhythmia, evaluation of sensing and therapy for arrhythmia termination), at time of initial
implantation or replacement with testing of cardiac contractility modulation-defibrillator pulse generator
0931T Electrophysiologic evaluation of cardiac contractility modulation-defibrillator leads, including defibrillation-threshold
evaluation (induction of arrhythmia, evaluation of sensing and therapy for arrhythmia termination), separate from initial
implantation or replacement with testing of cardiac contractility modulation-defibrillator pulse generator
 Implantation, replacement, repositioning, and removal of device are reported using new Category III codes 0915T-0925T

Added Codes
0932T Noninvasive detection of heart failure derived from augmentative analysis of an echocardiogram that demonstrated
preserved ejection fraction, with interpretation and report by a physician or other qualified health care professional
 Provides analysis of echocardiogram data to assess heart failure using algorithm
 May be separately reported from a concurrent or previously performed echocardiography procedure
(93306-93308, 93350, 93351)

Added Codes
0934T Remote monitoring of a wireless left atrial pressure sensor for up to 30 days, including data from daily uploads of left
atrial pressure recordings, interpretation(s) and trend analysis, with adjustments to the diuretics plan, treatment
paradigm thresholds, medications or lifestyle modifications, when performed, and report(s) by a physician or other
qualified health care professional
 Implantation of device reported using new Category III code 0933T
 Reported once per 30 days of monitoring
 Monitoring of less than 16 days may NOT be reported
 Monitoring of pulmonary artery pressure sensor is reported using 93264

Added Codes
0936T Photobiomodulation therapy of retina, single session
 Uses LEDs directly to the retina to stimulate cellular function
 Typically used to treat age-related macular degeneration or retinitis pigmentosa
 May be reported with modifier 50 if performed bilaterally

Added Codes
0937T External electrocardiographic recording for greater than 15 days up to 30 days by continuous rhythm recording and
storage; including recording, scanning analysis with report, review and interpretation by a physician or other qualified
health care professional
storage; recording (including connection and initial recording)
storage; scanning analysis with report
storage; review and interpretation by a physician or other qualified health care professional
 Reported once per each 30-day period of service
 Do NOT report in conjunction with 93224-93248 (external CV monitoring up to 15 days), 93268-93272(24-
hour attended monitoring), 99091, 99453, or 99454 (remote physiologic monitoring) for the same
monitoring period

Added Codes
0944T 3D contour simulation of target liver lesion(s) and margin(s) for image-guided percutaneous microwave ablation
 Includes simulation of liver lesion(s) to create ideal probe pathways and locations, perform volumetric
calculations of the ablation cavity, overlay proposed ablation volumes on CT scans of the liver, and compare
volume post ablation
 Reported once per microwave ablation session, regardless of number of tumors ablated
 Separate and distinct from intraoperative and other pre-procedure imaging guidance

Added Codes
0945T Intraoperative assessment for abnormal (tumor) tissue, in-vivo, following partial mastectomy (eg, lumpectomy) using
computer-aided fluorescence imaging (List separately in addition to code for primary procedure)
 Reported only once per procedure
 Report in conjunction with 19301 when computer-aided fluorescence imaging is performed to detect
residual abnormal tissue
 Do NOT report with 88172 (evaluation of FNA to determine specimen adequacy) or 0546T (intraoperative
radiofrequency spectroscopy to assess surgical margin)

Added Codes
0946T Orthopedic implant movement analysis using paired computed tomography (CT) examination of the target structure,
including data acquisition, data preparation and transmission, interpretation and report (including CT scan of the
joint or extremity performed with paired views)
 Two CT scans are acquired at the extreme endpoints of movement to perform an analysis of implant
movement
 Do NOT report CT scan of joint or extremity separately

Added Codes
0947T Magnetic resonance image guided low intensity focused ultrasound (MRgFUS), stereotactic blood-brain barrier
disruption using microbubble resonators to increase the concentration of blood-based biomarkers of target,
intracranial, including stereotactic navigation and frame placement, when performed
 Non-invasive method of combining MRI scanning with low-intensity focused ultrasound delivery to identify
intracranial tumors

Deleted Codes
0398T – Magnetic resonance image guided high intensity focused ultrasound
(MRgFUS), stereotactic ablation lesion, intracranial for movement disorder
including stereotactic navigation and frame placement when performed
61715
0500T - Infectious agent detection by nucleic acid (DNA or RNA), Human
Papillomavirus (HPV) for five or more separately reported high-risk HPV types (eg,
16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) (ie, genotyping)
87624-87626
G0476
0564T - Oncology, chemotherapeutic drug cytotoxicity assay of cancer stem cells
(CSCs), from cultured CSCs and primary tumor cells, categorical drug response
reported based on percent of cytotoxicity observed, a minimum of 14 drugs or
drug combinations
89240

Revised Codes – New & Emerging Technology
0615T Automated analysis of binocular eye movements without spatial
calibration, including disconjugacy, saccades, and pupillary dynamics
for the assessment of concussion, with interpretation and report
Eye-movement analysis without spatial calibration, with
interpretation and report

Questions?
Jennifer Bishop
hcwebinars@healthcatalyst.com

2025 CPT® Code Updates ( CDM Focused )

More Related Content

Similar to 2025 CPT® Code Updates ( CDM Focused ) (20)

More from Health Catalyst (20)

Recently uploaded (20)

2025 CPT® Code Updates ( CDM Focused )

Editor's Notes